13F History
Schedule 13D/G History
Ownership
Other Reports

Redmile Group, LLC - Significant Ownership

Signature - Title: Joshua Garcia - Authorized Signatory
Location: San Francisco, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Redmile Group, LLC.

Significant Ownership of Redmile Group, LLC

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FATE	FATE THERAPEUTICS INC	Common Stock, $0.001 par value per share	14.9%	$18.5M		17.8M		Redmile Group, LLC	Dec 20, 2024
SRRK	Scholar Rock Holding Corporation	Common Stock, par value $0.001 per share	9.9%	$354M		9.89M		Redmile Group, LLC	Dec 31, 2024
NGNE	Neurogene Inc.	Common Stock, $0.000001 par value	9.9%	$24.9M		1.48M		Redmile Group, LLC	Dec 31, 2024
RAPT	RAPT Therapeutics, Inc.	Common Stock, $0.0001 par value per share	9.9%	$17.4M		13.9M		Redmile Group, LLC	Dec 31, 2024
GRTS	Gritstone bio, Inc.	Common Stock, $0.0001 par value per share	8.2%	$132K		13.2M		Redmile Group, LLC	Dec 31, 2024
ZYME	Zymeworks Inc.	Common Stock, par value $0.00001 per share	7%	$59.4M		4.84M		Redmile Group, LLC	Dec 31, 2024
	Silence Therapeutics plc	Ordinary Shares, nominal value GBP 0.05 per share	5.1%			7.2M		Redmile Group, LLC	Dec 31, 2024
PLRX	Pliant Therapeutics, Inc.	Common Stock, par value $0.0001 per share	4.8%	$4.4M		2.9M		Redmile Group, LLC	Dec 31, 2024
FOLD	Amicus Therapeutics, Inc.	Common Stock, par value $0.01 per share	4.6%	$126M		14.2M		Redmile Group, LLC	Dec 31, 2024

Showing 1 to 9 of 9 entries

Schedules 13D/G Reported by Redmile Group, LLC:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.